Olon Confirms Construction Timeline for New Facility

Olon, a global pharmaceutical CDMO and API provider, has confirmed the construction timeline for its new facility dedicated to ultra-potent compounds in Rodano. The company has already completed the installation and validation of a new small-scale production area within the facility. The installation of the large-scale production plant is nearing completion, with an expected finish date of January 2025.
 
The new facility, designed to produce payloads, linker payloads, and ultra-potent APIs, is already equipped for small-scale GMP production. It features advanced systems for high-level control, a dedicated quality control department, and storage areas for active ingredients.
 
“It is a new line that is highly advanced not only in terms of the technological level of its production facilities and design but also because it represents a real ‘factory within a factory,’ with a warehouse area and a QC department. This will make it possible to handle highly active molecules in a straightforward and safe way, reducing the risks of contamination,” explains Marcello Buson, Head of Global Operations of the Olon Group.
 
The facility is equipped with an HPLC preparation system for product purification, a lyophilizer for isolation, and a wide range of analytical instruments.